The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia.
Open accessAbstract
High-density lipoprotein (HDL) has been found to neutralize LPS activity in vitro and in animals in vivo. We sought to determine the effects of reconstituted HDL (rHDL) on LPS responsiveness in humans in a double-blind, randomized, placebo-controlled, cross-over study. rHDL, given as a 4-h infusion at 40 mg/kg starting 3.5 h before endotoxin challenge (4 ng/kg), reduced flu-like symptoms during endotoxemia, but did not influence the febrile response. rHDL potently reduced the endotoxin-induced release of TNF, IL-6, and IL-8, while only modestly attenuating the secretion of proinflammatory cytokine inhibitors IL-1ra, soluble TNF receptors and IL-10. In addition, rHDL attenuated LPS-induced changes in leukocyte counts and the enhanced expression of CD11b/CD18 on granulocytes. Importantly, rHDL infusion per se, before LPS administration, was associated with a downregulation of CD14, the main LPS receptor, on monocytes. This effect was biologically relevant, since monocytes isolated from rHDL-treated whole blood showed reduced expression of CD14 and diminished TNF production upon stimulation with LPS. These results suggest that rHDL may inhibit LPS effects in humans in vivo not only by binding and neutralizing LPS but also by reducing CD14 expression on monocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,987
Receptor-Dependent Mechanisms of Cell Stimulation by Bacterial Endotoxin
Ulevitch, R. J., & Tobias, P. S. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.002253 · Cited by 1,442
van Deventer, S., Buller, H., ten Cate, J., Aarden, L., Hack, C., & Sturk, A. (1990) · Blood · doi:10.1182/blood.v76.12.2520.2520 · Cited by 851
Self-citationSoluble CD14 participates in the response of cells to lipopolysaccharide.
Frey, E. A., Miller, D. S., Jahr, T. G., Sundan, A., Bazil, V, Espevik, T., Finlay, B. B., & Wright, S. D. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1665 · Cited by 682
CD14: Cell surface receptor and differentiation marker
Ziegler-Heitbrock, H. W. L., & Ulevitch, R. J. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90212-4 · Cited by 584
Arfors, K., Lundberg, C., Lindbom, L., Lundberg, K., Beatty, P., & Harlan, J. (1987) · Blood · doi:10.1182/blood.v69.1.338.338 · Cited by 524
In vivo protection against endotoxin by plasma high density lipoprotein.
Levine, D. M., Parker, T. S., Donnelly, T. M., Walsh, A., & Rubin, A. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.12040 · Cited by 485
Wurfel, M. M., Kunitake, S. T., Lichenstein, H., Kane, J. P., & Wright, S. D. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.1025 · Cited by 442
Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes
Bazil, V, & Strominger, J. L. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.5.1567 · Cited by 424
Lipopolysaccharide Binding Protein-mediated Complexation of Lipopolysaccharide with Soluble CD14
Tobias, P. S., Soldau, K., Gegner, J. A., Mintz, D., & Ulevitch, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10482 · Cited by 324
Cited by
Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300019-jlr200 · Cited by 1,481
Cholesterol, inflammation and innate immunity.
Tall, A. R., & Yvan-Charvet, L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3793 · Cited by 1,479
Dietary lipids, gut microbiota and lipid metabolism
Schoeler, M., & Caesar, R. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09512-0 · Cited by 1,163
Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock
Van Amersfoort, E. S., Van Berkel, T. J. C., & Kuiper, J. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.379-414.2003 · Cited by 750
Role of HDL, ABCA1, and ABCG1 Transporters in Cholesterol Efflux and Immune Responses
Yvan-Charvet, L., Wang, N., & Tall, A. R. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179283 · Cited by 680
Kontush, A., & Chapman, M. J. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.1 · Cited by 647
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
van Deuren, M., Brandtzaeg, P., & van der Meer, J. W. M. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.1.144 · Cited by 588
Dyslipidemia and inflammation: an evolutionary conserved mechanism
Esteve, E., Ricart, W., & Fernández-Real, J. M. (2005) · Clinical Nutrition · doi:10.1016/j.clnu.2004.08.004 · Cited by 492
Lactoferrin as a natural immune modulator
Actor, J., Hwang, S.-A., & Kruzel, M. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788453202 · Cited by 455
“Both endotoxemia and bacteremia are manifested by severe clinical syndromes characterized by proinflammatory cytokine release, increased expression of adhesion molecules, and massive release of reactive oxygen species [68–70].”
BackgroundHigh-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men
Spieker, L. E., Sudano, I., Hürlimann, D., Lerch, P. G., Lang, M. G., Binggeli, C., Corti, R., Ruschitzka, F., Lüscher, T. F., & Noll, G. (2002) · Circulation · doi:10.1161/01.cir.0000013424.28206.8f · Cited by 438
Self-citationAgeing, tumour necrosis factor-alpha (TNF-α) and atherosclerosis
Bruunsgaard, H., Skinhøj, P., Pedersen, A. N., Schroll, M., & Pedersen, B. K. (2008) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2000.01281.x · Cited by 402
New Insights into the Biology of the Acute Phase Response
Suffredini, A. F., Fantuzzi, G., Badolato, R., Oppenheim, J. J., & O'Grady, N. P. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020563913045 · Cited by 391
Hyka, N., Dayer, J.-M., Modoux, C., Kohno, T., Edwards, C. K., Roux-Lombard, P., & Burger, D. (2001) · Blood · doi:10.1182/blood.v97.8.2381 · Cited by 389
ACUTE RESPIRATORY DISTRESS SYNDROME
Conner, B. D., & Bernard, G. R. (2000) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70167-2 · Cited by 382
Chien, J.-Y., Jerng, J.-S., Yu, C.-J., & Yang, P.-C. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000171183.79525.6b · Cited by 379
Lipoprotein metabolism in patients with severe sepsis
van Leeuwen, H. J., Heezius, E. C. J. M., Dallinga, G. M., van Strijp, J. A. G., Verhoef, J., & van Kessel, K. P. M. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000059724.08290.51 · Cited by 378
Gao, W., Xiong, Y., Li, Q., & Yang, H. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00508 · Cited by 353
Jayashree, B., Bibin, Y. S., Prabhu, D., Shanthirani, C. S., Gokulakrishnan, K., Lakshmi, B. S., Mohan, V., & Balasubramanyam, M. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1911-4 · Cited by 353
LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria.
Lamping, N., Dettmer, R., Schröder, N. W., Pfeil, D., Hallatschek, W., Burger, R., & Schumann, R. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2338 · Cited by 344
Metabolic endotoxemia and diabetes mellitus: A systematic review
Gomes, J. M. G., Costa, J. D. A., & Alfenas, R. D. C. G. (2017) · Metabolism · doi:10.1016/j.metabol.2016.12.009 · Cited by 334
German, J. B., & Dillard, C. J. (2006) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408690590957098 · Cited by 315
HDL in innate and adaptive immunity
Catapano, A. L., Pirillo, A., Bonacina, F., & Norata, G. D. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu150 · Cited by 299
Saturated fats: what dietary intake?
German, J. B., & Dillard, C. J. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.3.550 · Cited by 292
Bisoendial, R. J., Hovingh, G. K., Levels, J. H. M., Lerch, P. G., Andresen, I., Hayden, M. R., Kastelein, J. J. P., & Stroes, E. S. G. (2003) · Circulation · doi:10.1161/01.cir.0000070934.69310.1a · Cited by 288
Self-citationPotential Role of Endotoxin as a Proinflammatory Mediator of Atherosclerosis
Stoll, L. L., Denning, G. M., & Weintraub, N. L. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000147534.69062.dc · Cited by 288
The importance of the gastrointestinal system in the pathogenesis of heart failure
Krack, A., Sharma, R., Figulla, H. R., & Anker, S. D. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi389 · Cited by 280
Katz, J., Flugelman, M. Y., Goldberg, A., & Heft, M. (2002) · Journal of Periodontology · doi:10.1902/jop.2002.73.5.494 · Cited by 258
A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk
German, J. B., Gibson, R. A., Krauss, R. M., Nestel, P., Lamarche, B., van Staveren, W. A., Steijns, J. M., de Groot, L. C. P. G. M., Lock, A. L., & Destaillats, F. (2009) · European Journal of Nutrition · doi:10.1007/s00394-009-0002-5 · Cited by 257
Metabolic endotoxemia: a molecular link between obesity and cardiovascular risk
Neves, A. L., Coelho, J., Couto, L., Leite-Moreira, A., & Roncon-Albuquerque, R. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0079 · Cited by 211
Cai, L., Ji, A., de Beer, F. C., Tannock, L. R., & van der Westhuyzen, D. R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci31539 · Cited by 167
Nazir, S., Jankowski, V., Bender, G., Zewinger, S., Rye, K.-A., & van der Vorst, E. P. C. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.10.006 · Cited by 140
Jahagirdar, R., Zhang, H., Azhar, S., Tobin, J., Attwell, S., Yu, R., Wu, J., McLure, K. G., Hansen, H. C., Wagner, G. S., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.06.008 · Cited by 134
Bahador, M., & Cross, A. S. (2007) · Journal of Endotoxin Research · doi:10.1177/0968051907085986 · Cited by 108
“TNF mediates responses to intravenous LPS Study Verbon et al. (2001)130 Subjects 16 M Inhibitor IC14 or placebo Objective To assess the role of IC14 in LPS-induced inflammation Results Anti-CD14 antibody can diminish inflammatory response induced by intravenous LPS and it might be beneficial in patients with Gram-nega…”
BackgroundInfluentialNguyen, M., Gautier, T., Masson, D., Bouhemad, B., & Guinot, P.-G. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072579 · Cited by 25
“This strategy has been demonstrated to improve survival in animal models of sepsis [82], and to decrease inflammation in healthy volunteers [83].”
Background
Metadata
- Authors
- Pajkrt, D., Doran, J. E., Koster, F., Lerch, P. G., Arnet, B., van der Poll, T., ten Cate, J. W., & van Deventer, S. J.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1996-11-01
- Volume
- 184
- Issue
- 5
- Pages
- 1601-1608
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2158092179
- Cited by
- 390
- References
- 27
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.